» Articles » PMID: 38939355

Expert Consensus on Clinical Trials of Human Xenotransplantation in China

Overview
Journal Health Care Sci
Date 2024 Jun 28
PMID 38939355
Authors
Affiliations
Soon will be listed here.
Abstract

The history of xenotransplantation started in the 19th century. After a few decades of investigation, significant breakthroughs and preclinical milestones have been achieved worldwide. With the recent transplantation of genetically modified porcine kidneys and heart into humans, these ground-breaking achievements have attracted great attention worldwide, in the hope that xenotransplantation might alleviate or even solve the problem of organ shortage. On January 20, 2022, the China Organ Transplantation Development Foundation convened a symposium on "The History, Current Situation and Future of Human Xenotransplantation Clinical Trials," where ways to promote the ethical and sustainable development of xenotransplantation in China were discussed among the participating experts. A formal consensus was reached as the product of the symposium, outlining the expert opinions on scientific, regulatory, and ethical issues of clinical trials of xenotransplantation in China.

Citing Articles

Artificial Liver Support Systems in Acute Liver Failure and Acute-on-Chronic Liver Failure: Systematic Review and Meta-Analysis.

Brown Jr R, Fisher R, Subramanian R, Griesemer A, Fernandes M, Thatcher W Crit Care Explor. 2025; 7(1):e1199.

PMID: 39804005 PMC: 11732652. DOI: 10.1097/CCE.0000000000001199.


Cardiac Xenotransplantation: A Narrative Review.

Thuan P, Dinh N Rev Cardiovasc Med. 2024; 25(7):271.

PMID: 39139422 PMC: 11317332. DOI: 10.31083/j.rcm2507271.


Expert consensus on clinical trials of human xenotransplantation in China.

Huang J Health Care Sci. 2024; 1(1):7-10.

PMID: 38939355 PMC: 11080631. DOI: 10.1002/hcs2.6.


From waste to wealth: Repurposing slaughterhouse waste for xenotransplantation.

Khan R, Khraibi A, Dumee L, Corridon P Front Bioeng Biotechnol. 2023; 11:1091554.

PMID: 36815880 PMC: 9935833. DOI: 10.3389/fbioe.2023.1091554.

References
1.
Meier R, Longchamp A, Mohiuddin M, Manuel O, Vrakas G, Maluf D . Recent progress and remaining hurdles toward clinical xenotransplantation. Xenotransplantation. 2021; 28(3):e12681. DOI: 10.1111/xen.12681. View

2.
Pan D, Liu T, Lei T, Zhu H, Wang Y, Deng S . Progress in multiple genetically modified minipigs for xenotransplantation in China. Xenotransplantation. 2019; 26(1):e12492. DOI: 10.1111/xen.12492. View

3.
Lopata K, Wojdas E, Nowak R, Lopata P, Mazurek U . Porcine Endogenous Retrovirus (PERV) - Molecular Structure and Replication Strategy in the Context of Retroviral Infection Risk of Human Cells. Front Microbiol. 2018; 9:730. PMC: 5932395. DOI: 10.3389/fmicb.2018.00730. View

4.
Niu D, Wei H, Lin L, George H, Wang T, Lee I . Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9. Science. 2017; 357(6357):1303-1307. PMC: 5813284. DOI: 10.1126/science.aan4187. View

5.
Ekser B, Li P, Cooper D . Xenotransplantation: past, present, and future. Curr Opin Organ Transplant. 2017; 22(6):513-521. PMC: 5935127. DOI: 10.1097/MOT.0000000000000463. View